Mar 3, 2026
BMO Capital maintained an Outperform rating and raised the price target to $600 for Vertex Pharmaceuticals Incorporated on…
ANALYST COVERAGE
Mar 3, 2026
Benchmark maintained its Buy rating on EVgo, Inc. (EVGO) on March 02, 2026. This EVGO analyst rating note…
Mar 3, 2026
William Blair maintained an Outperform rating on AAON, Inc. (AAON) on March 02, 2026. This AAON analyst rating…
Mar 3, 2026
RBC Capital maintained Acadia Healthcare Company, Inc. (ACHC) at Outperform on March 2, 2026, marking the primary change…
Mar 3, 2026
We’ve detected unusual activity from your computer network To continue, please click the box below to let us…
Mar 3, 2026
Cowen & Co. on March 02, 2026 maintained a Buy rating on Samsara Inc. (IOT) while cutting its…
Mar 3, 2026
Cowen & Co. on March 2, 2026 maintained a Buy on BrightSpring Health Services, Inc. Common Stock (BTSG)…
Mar 3, 2026
On March 02, 2026 at 09:37 AM the EVH analyst rating from Cowen & Co. stayed at Buy…
Mar 3, 2026
Raymond James maintained its Outperform rating on Oshkosh Corporation (OSK) on March 02, 2026. That is the lead…
Mar 3, 2026
Craig-Hallum maintained a Buy on Globalstar (GSAT) on March 2, 2026, and raised the price target to $70.…
Mar 3, 2026
On March 02, 2026 William Blair maintained an Outperform rating on Ocular Therapeutix, Inc. (OCUL), marking the most…
Mar 3, 2026
Bank of America Securities on March 2, 2026 maintained Neutral on Intellia Therapeutics (NTLA). This NTLA analyst rating…